Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integrating T cell metabolism in cancer immunotherapy.
Dugnani E, Pasquale V, Bordignon C, Canu A, Piemonti L, Monti P. Dugnani E, et al. Cancer Lett. 2017 Dec 28;411:12-18. doi: 10.1016/j.canlet.2017.09.039. Epub 2017 Sep 30. Cancer Lett. 2017. PMID: 28974448 Review.
CXCR1/2 inhibition enhances pancreatic islet survival after transplantation.
Citro A, Cantarelli E, Maffi P, Nano R, Melzi R, Mercalli A, Dugnani E, Sordi V, Magistretti P, Daffonchio L, Ruffini PA, Allegretti M, Secchi A, Bonifacio E, Piemonti L. Citro A, et al. Among authors: dugnani e. J Clin Invest. 2012 Oct;122(10):3647-51. doi: 10.1172/JCI63089. Epub 2012 Sep 17. J Clin Invest. 2012. PMID: 22996693 Free PMC article. Clinical Trial.
Rapamycin unbalances the polarization of human macrophages to M1.
Mercalli A, Calavita I, Dugnani E, Citro A, Cantarelli E, Nano R, Melzi R, Maffi P, Secchi A, Sordi V, Piemonti L. Mercalli A, et al. Among authors: dugnani e. Immunology. 2013 Oct;140(2):179-90. doi: 10.1111/imm.12126. Immunology. 2013. PMID: 23710834 Free PMC article. Clinical Trial.
Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients.
Balzano G, Dugnani E, Pasquale V, Capretti G, Radaelli MG, Garito T, Stratta G, Nini A, Di Fenza R, Castoldi R, Staudacher C, Reni M, Scavini M, Doglioni C, Piemonti L. Balzano G, et al. Among authors: dugnani e. Acta Diabetol. 2014 Oct;51(5):801-11. doi: 10.1007/s00592-014-0614-y. Epub 2014 Jun 29. Acta Diabetol. 2014. PMID: 24974302
Diabetes after pancreatic surgery: novel issues.
Scavini M, Dugnani E, Pasquale V, Liberati D, Aleotti F, Di Terlizzi G, Petrella G, Balzano G, Piemonti L. Scavini M, et al. Among authors: dugnani e. Curr Diab Rep. 2015 Apr;15(4):16. doi: 10.1007/s11892-015-0589-2. Curr Diab Rep. 2015. PMID: 25702096 Review.
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial.
Reni M, Dugnani E, Cereda S, Belli C, Balzano G, Nicoletti R, Liberati D, Pasquale V, Scavini M, Maggiora P, Sordi V, Lampasona V, Ceraulo D, Di Terlizzi G, Doglioni C, Falconi M, Piemonti L. Reni M, et al. Among authors: dugnani e. Clin Cancer Res. 2016 Mar 1;22(5):1076-85. doi: 10.1158/1078-0432.CCR-15-1722. Epub 2015 Oct 12. Clin Cancer Res. 2016. PMID: 26459175 Clinical Trial.
Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells.
Bonomi A, Sordi V, Dugnani E, Ceserani V, Dossena M, Coccè V, Cavicchini L, Ciusani E, Bondiolotti G, Piovani G, Pascucci L, Sisto F, Alessandri G, Piemonti L, Parati E, Pessina A. Bonomi A, et al. Among authors: dugnani e. Cytotherapy. 2015 Dec;17(12):1687-95. doi: 10.1016/j.jcyt.2015.09.005. Epub 2015 Oct 21. Cytotherapy. 2015. PMID: 26481416
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma.
Belli C, Piemonti L, D'Incalci M, Zucchetti M, Porcu L, Cappio S, Doglioni C, Allavena P, Ceraulo D, Maggiora P, Dugnani E, Cangi MG, Garassini G, Reni M. Belli C, et al. Among authors: dugnani e. Cancer Chemother Pharmacol. 2016 Mar;77(3):477-84. doi: 10.1007/s00280-015-2932-3. Epub 2015 Dec 14. Cancer Chemother Pharmacol. 2016. PMID: 26666646 Clinical Trial.
36 results